Literature DB >> 11872288

Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma.

Hiroya Ojiri1, William M Mendenhall, Scott P Stringer, Patches L Johnson, Anthony A Mancuso.   

Abstract

PURPOSE: To establish whether the extent of neck disease on postradiation therapy (RT) computed tomography (CT) can predict the likelihood of positive neck nodes and, thereby, the necessity of planned post-RT neck dissection. METHODS AND MATERIALS: Ninety-five patients who underwent post-RT neck dissection within 2 months for squamous cell carcinoma of the head and neck were eligible. Of the 95 patients, 37 (32.7%) of 113 hemineck specimens were pathologically positive. On post-RT CT imaging studies, the number and size of lymph nodes >1 cm were recorded. Internal focal defects and the likelihood of extracapsular spread were graded.
RESULTS: If lymph nodes on post-RT CT were < or = 15 mm, free of significant internal focal low-attenuation or calcification, and without imaging evidence of extracapsular spread, the surgical hemineck specimen was positive in 1 (3.4%) of the 29 hemineck specimens. A focal low-attenuation defect (p = 0.0078) and evidence of extracapsular spread (p = 0.0721) seen in the residual nodal mass on CT were independent predictors of a positive surgical specimen by multivariate analysis.
CONCLUSION: CT findings on post-RT neck studies can help predict the likelihood of residual disease and, thereby, the necessity of planned post-RT neck dissection.

Entities:  

Mesh:

Year:  2002        PMID: 11872288     DOI: 10.1016/s0360-3016(01)02603-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  Detection of residual disease of lymph node metastases in the neck, which is treated by (chemo)radiation.

Authors:  J A Castelijns; C R Leemans
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

2.  Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy.

Authors:  Hiroya Ojiri; Anthony A Mancuso; William M Mendenhall; Scott P Stringer
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

3.  Evaluation of nodal response after intra-arterial chemoradiation for node-positive head and neck cancer.

Authors:  Tomohiro Sakashita; Akihiro Homma; Nobuhiko Oridate; Hiromitsu Hatakeyama; Satoshi Kano; Takatsugu Mizumachi; Satoshi Fukuda
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-01       Impact factor: 2.503

Review 4.  Treatment of advanced neck metastases.

Authors:  G Spriano; R Pellini; V Manciocco; P Ruscito
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-12       Impact factor: 2.124

5.  Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer.

Authors:  Anuj Goenka; Luc G T Morris; Shyam S Rao; Suzanne L Wolden; Richard J Wong; Dennis H Kraus; Nisha Ohri; Jeremy Setton; Benjamin H Lok; Nadeem Riaz; Borys R Mychalczak; Heiko Schoder; Ian Ganly; Jatin P Shah; David G Pfister; Michael J Zelefsky; Nancy Y Lee
Journal:  Int J Cancer       Date:  2013-03-29       Impact factor: 7.396

6.  Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapy.

Authors:  Giuseppe Sanguineti; Francesco Ricchetti; Binbin Wu; Nishant Agrawal; Christine Gourin; Harold Agbahiwe; Shanthi Marur; Stefania Clemente; Todd McNutt; Arlene Forastiere
Journal:  Head Neck       Date:  2012-01-20       Impact factor: 3.147

Review 7.  Positron emission tomography for neck evaluation following definitive treatment with chemoradiotherapy for locoregionally advanced head and neck squamous cell carcinoma.

Authors:  Voichita Bar-Ad; Mark Mishra; Nitin Ohri; Charles Intenzo
Journal:  Rev Recent Clin Trials       Date:  2012-02

8.  Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck.

Authors:  Daniel A Hamstra; Kuei C Lee; Bradford A Moffat; Thomas L Chenevert; Alnawaz Rehemtulla; Brian D Ross
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

9.  Improving imaging diagnosis of persistent nodal metastases after definitive therapy for oropharyngeal carcinoma: specific signs for CT and best performance of combined criteria.

Authors:  J D Hamilton; S Ahmed; V C Sandulache; S P Daram; T J Ow; H D Skinner; A Rao; L E Ginsberg; A J Kumar; J N Myers
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-07       Impact factor: 3.825

10.  Monitoring of treatment response after chemoradiotherapy for head and neck cancer using in vivo 1H MR spectroscopy.

Authors:  Ann D King; David K W Yeung; Kwok-Hung Yu; Frankie K F Mo; Chen-Wen Hu; Kunwar S Bhatia; Gary M K Tse; Alexander C Vlantis; Jeffrey K T Wong; Anil T Ahuja
Journal:  Eur Radiol       Date:  2009-08-05       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.